American Well Corp — fact timeline

American Well Corp shareholders approved Advisory Vote on Named Executive Officer Compensation at the 2026-06-16 meeting.

“Proposal 3 — Advisory Vote on Named Executive Officer Compensation The stockholders of the Company approved, by a non-binding advisory vote, the compensation paid to the company’s named executive officers, as disclosed in the Executive Compensation section and the related compensation tables and narrative disclosure in the proxy statement. The voting results are as follows: For Withheld Broker Non-Votes 21,137,741 326,662 2,507,946”

American Well Corp shareholders approved Ratifying the Appointment of the Independent Registered Public Accounting Firm at the 2026-06-16 meeting.

“Proposal 2 — Ratifying the Appointment of the Independent Registered Public Accounting Firm The stockholders of the Company ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The voting results are as follows: For Withheld Broker Non-Votes 23,945,239 27,110 -”

American Well Corp shareholders approved Election of Directors at the 2026-06-16 meeting.

“Proposal 1 — Election of Directors The stockholders of the Company elected the following Class III director nominee proposed by the Company’s Board of Directors to serve until the 2029 annual meeting of stockholders of the Company or until his respective successor has been duly elected and qualified. The voting results are as follows: Name For Withheld Broker Non-Votes Dr. Ido Schoenberg 20,509,462 954,941 2,507,946”

Roy Schoenberg resigned as Executive Vice Chairman of the Board at American Well Corp.

“Dr. Roy Schoenberg notified American Well Corporation (the “Company”) of his resignation from the Company’s Board of Directors, effective immediately.”

American Well Corp reported Q2 2026 results: revenue $48- $52 million. Guidance initiated.

“The company also provided financial guidance for Q2 2026 Revenue and adjusted EBITDA: • Q2 revenue in the range of $48- $52 million • Q2 adjusted EBITDA in the range of ($4) – ($2) million.”

American Well Corp reported 2026 full year results: revenue $195 to $205 million. Guidance reaffirmed.

“The company reaffirmed its 2026 revenue and AMG visits guidance and updated its Adjusted EBITDA outlook: • Revenue in the range of $195 to $205 million • AMG visits between 1.32 and 1.37 million • Adjusted EBITDA in the range of between ($16) million to ($12) million.”

American Well Corp reported Q1 2026 results: revenue Recorded Total Revenue of $54.9 million, net income Net loss was ($10.3) million.

“Recorded Total Revenue of $54.9 million exceeding the previously provided financial guidance for Q1 o Achieved subscription revenue of $24.9 million o Recorded Amwell Medical Group (“AMG”) visit revenue of $28.9 million • Reported gross margin of 51% • Net loss was ($10.3) million, compared to ($25.2) million in fourth quarter of 2025, continuously moving from quarter to quarter in a favorable trajectory”

American Well Corp amended Amended and Restated Statement of Work with Elevance Health, Inc. f/n/a/ Anthem Inc. (effective 2026-01-01).

“On January 5, 2026, American Well Corporation (the “Company”) entered into an Amended and Restated Statement of Work (the “SOW”) with Elevance Health, Inc. f/n/a/ Anthem Inc. (“Elevance Health”), effective as of January 1, 2026, replacing the Statement of Work dated January 1, 2023 between the parties, and extending the parties’ partnership pursuant to which the Company operates a white-labelled digital care delivery platform on behalf of Elevance Health under the brand name LiveHealth Online®.”

American Well Corp amended Provider Agreement Amendments with Elevance Health related entities (effective 2025-12-24).

“Online Care Group, PC (“OCG”), the Company’s clinical partner, entered into amendments to two provider agreements (collectively, the “Provider Agreement Amendments”) with Elevance Health related entities”

American Well Corp entered into Healthy Impact SOW with Elevance Health, Inc. f/n/a/ Anthem Inc. (effective 2025-12-25).

“on December 25, 2025 entered into a related Statement of Work updating the Company’s Healthy Impact service offerings (the “Healthy Impact SOW”), effective as of January 1, 2026”

American Well Corp amended Master Services Agreement with Elevance Health, Inc. f/n/a/ Anthem Inc. (effective 2025-12-24).

“On December 24, 2025, American Well Corporation (the “Company”) entered into an amendment to extend its Master Services Agreement dated January 1, 2023 (the “MSA”) with Elevance Health, Inc. f/n/a/ Anthem Inc. (“Elevance Health”)”

Vaughn Paunovich departed as EVP, Enterprise Platforms at American Well Corp.

“Mr. Paunovich’s employment with the Company will end on March 2, 2025.”

American Well Corp completed a disposition involving Avel eCare, LLC for $20,714,459 (closed 2025-01-08).

“contracts and the related accounts receivable and all accounts payable and accrued expenses of the Business. The purchase price is comprised of (i) an upfront cash payment of $20,714,459, which is equal to 1.1x the Business’ trailing twelve-month revenue, excluding on-site revenue attributable to certain of the Business’ contracts, subject to customary adjustments”

Mark Hirschhorn was appointed as Chief Financial Officer at American Well Corp.

“Effective November 4, 2024, the Company will grant awards to its new Chief Financial Officer, Mark Hirschhorn, under the Inducement Plan.”

Mark Hirschhorn was appointed as Chief Financial Officer at American Well Corp.

“the Board of Directors of the Company (the “Board”) appointed Mark Hirschhorn to serve as the Company’s CFO, effective October 21, 2024”

Robert Shepardson resigned as Chief Financial Officer at American Well Corp.

“Mr. Robert Shepardson informed American Well Corporation (the “Company”) of his intention to resign as Chief Financial Officer (“CFO”), effective October 18, 2024.”

Rivka "Ricky" Goldwasser was appointed as Class II Director at American Well Corp.

“On June 13, 2024, the Board of Directors (the "Board") of American Well Corporation (the "Company") appointed Rivka "Ricky" Goldwasser as a Class II director of the Company.”

Roy Schoenberg was appointed as Executive Vice Chairman at American Well Corp.

“Dr. Roy Schoenberg resigned as the President & Co-Chief Executive Officer of American Well Corporation (the “Company”), effective June 13, 2024. Dr. Schoenberg’s decision to resign was related to his appointment as our Executive Vice Chairman”

American Well Corp received a nyse noncompliance notice notice regarding minimum bid price (rules 802.01C).

“April 2, 2024, American Well Corporation (the “Company”) received a notice from the New York Stock Exchange (the “NYSE”) that the Company was not in compliance with the continued listing minimum price criteria set forth in Section 802.01C of the NYSE’s Listed Company Manual (“Section 802.01C”) because the average closing price of the Company’s Class A Common Stock (the “Common Stock”) was less than $1.00 per share over a consecutive 30 trading-day period. The notice has no immediate impact on the listing of the Common Stock on the NYSE, subject to the Company’s compliance with the NYSE’s other”

American Well Corp reported fourth quarter and full year ended December 31, 2023 results: revenue Total Revenue of $70.7 million, net income Net loss was ($50.0) million.

“With the achievements of 2023, we begin 2024 with high conviction regarding our path to profitability.” Amwell Fourth Quarter 2023 Highlights: • Recorded Total Revenue of $70.7 million o Achieved subscription revenue of $27.3 million o Recorded Amwell Medical Group (“AMG”) visit revenue of $32.1 million • Reported gross margin of 34% • Net loss was ($50.0)”

Deval Patrick departed as Director at American Well Corp.

“On December 21, 2023, Deval Patrick notified American Well Corporation (the “Company”) that he will resign from the Board of Directors, effective on the date of the Company’s next annual meeting of stockholders to be held in 2024.”

American Well Corp reported third quarter ended Sept. 30, 2023 results: revenue $61.9 million, net income ($137.1) million. Guidance reaffirmed.

“leader in hybrid care enablement, today announced financial results for the third quarter ended Sept. 30, 2023. Amwell Third Quarter 2023 Highlights: • Recorded Total Revenue of $61.9 million o Achieved subscription revenue of $28.4 million o Recorded Amwell Medical Group (“AMG”) visit revenue of $26.7 million • Reported gross margin of 35% • Net loss was ($137.1)”

American Well Corp reported second quarter ended June 30, 2023 results: revenue $62.4 million, net income ($93.5) million. Guidance lowered.

“Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, today announced financial results for the second quarter ended June 30, 2023. Amwell Second Quarter 2023 Highlights: • Recorded Total Revenue of $62.4 million o Achieved subscription revenue of $28.0 million o Recorded AMG Visit revenue of $28.1 million • Reported gross margin of 39% • Net loss was ($93.5) million”

American Well Corp shareholders approved Advisory vote on the compensation of the named executive officers at the 2023-06-22 meeting.

“The stockholders of the Company approved, by a non-binding advisory vote, the compensation paid to the company’s named executive officers, as disclosed in the Compensation Discussion and Analysis and the related compensation tables and narrative disclosure in the proxy statement. The voting results are as follows: For Withheld Broker Non-Votes 343,920,194 34,803,341 23,291,673”

American Well Corp shareholders approved Ratifying the Appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2023 at the 2023-06-22 meeting.

“The stockholders of the Company ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. The voting results are as follows: For Withheld Broker Non-Votes 400,948,563 1,066,645 -”

American Well Corp shareholders approved Election of Class III Director Nominees at the 2023-06-22 meeting.

“The stockholders of the Company elected each of the following Class III director nominees proposed by the Company’s Board of Directors to serve until the 2026 annual meeting of stockholders of the Company or until their respective successors have been duly elected and qualified. The voting results for each director nominee are as follows: Name For Withheld Broker Non-Votes Dr. Peter Slavin 335,472,295 43,251,240 23,291,673 Dr. Ido Schoenberg 373,544,093 5,179,442 23,291,673 Dr. Roy Schoenberg 373,908,389 4,815,146 23,291,673”

American Well Corp reported first quarter ended March 31, 2023 results: revenue $64.0 million, net income ($398.5) million. Guidance reaffirmed.

“in digital healthcare enablement, today announced financial results for the first quarter ended March 31, 2023. Amwell First Quarter 2023 Highlights: • Recorded Total Revenue of $64.0 million o Achieved subscription revenue of $28.7 million o Recorded AMG Visit revenue of $32.5 million • Reported gross margin of 39.5% • Net loss was ($398.5) million, compared to”

American Well Corp reported the full year ended December 31, 2022 results: revenue $277.2 million, net income $272.1 million. Guidance initiated.

“Total Revenue grew 10% to $277.2 million, compared to $252.8 million”

American Well Corp reported the fourth quarter ended December 31, 2022 results: revenue $79.2 million, net income ($61.6) million. Guidance initiated.

“Recorded total revenue of $79.2 million in the fourth quarter of 2022, representing 9% growth compared to $72.8 million in the fourth quarter of 2021”

American Well Corp entered into Provider Agreements with Elevance Health related entities (effective 2022-11-28).

“In addition, on November 28, 2022, Online Care Group, PC (“OCG”), the Company’s clinical partner, entered into two different provider agreements (collectively, the “Provider Agreements”) with Elevance Health related entities.”

American Well Corp entered into Master Services Agreement and Statement of Work with Elevance Health, Inc. f/n/a/ Anthem Inc. (effective 2022-11-28).

“On November 28, 2022, American Well Corporation (the “Company”) entered into a Master Services Agreement (the “MSA”) and related Statement of Work (the “SOW”, and together with the MSA, the “Agreements”) with Elevance Health, Inc. f/n/a/ Anthem Inc. (“Elevance Health”), effective as of January 1, 2023”

American Well Corp updated its third quarter ended September 30, 2022 guidance (reaffirmed).

“On November 7, 2022, American Well Corporation issued a press release announcing its financial results for the fiscal quarter ended September 30, 2022.”

Robert Webb was appointed as Class I director at American Well Corp.

“Effective October 31, 2022, the Board of Directors (the " Board ") of American Well Corporation (the " Company ") appointed Robert Webb as a Class I director of the Company.”

Phyllis Gotlib changed role as EVP and President, American Well International at American Well Corp.

“Pursuant to the Gotlib Amendment, Ms. Gotlib’s title was changed to EVP and President, American Well International.”

Kurt Knight changed role as EVP and Chief Operating Officer at American Well Corp.

“Pursuant to the Knight Amendment, Mr. Knight’s title was changed to EVP and Chief Operating Officer.”

Robert Shepardson changed role as EVP and Chief Financial Officer at American Well Corp.

“Pursuant to the Shepardson Amendment, Mr. Shepardson’s title was changed to EVP and Chief Financial Officer.”

Brendan O'Grady resigned as Chief Commercial & Growth Officer at American Well Corp.

“On May 19, 2022, Brendan O’Grady informed American Well Corporation (the “Company”) of his intention to resign as Chief Commercial & Growth Officer, effective June 3, 2022.”